Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

13.50
Delayed Data
As of Apr 21
 +0.15 / +1.12%
Today’s Change
7.75
Today|||52-Week Range
37.20
+1.89%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close13.35
Today’s open13.30
Day’s range12.70 - 13.55
Volume1,863,849
Average volume (3 months)1,917,501
Market cap$996.4M
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)-1,327.78%
Earnings growth (this year)-36.71%
Earnings growth (next 5 years)+8.07%
Revenue growth (last year)-4.19%
P/E ratioNM
Price/Sales1.14
Price/Book1.59

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc0.000.00%
CORTCorcept Therapeutics...-0.88-8.81%
AIMTAimmune Therapeutics...-0.58-2.95%
ALDRAlder Biopharmaceuti...-0.25-1.20%
Data as of 4:00pm ET, 04/21/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)$0.13
Annual revenue (last year)$824.4M
Annual profit (last year)-$472.0M
Net profit margin-57.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts


Search for Jobs